Other Species / Isoforms
  PPAR-alpha (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6
__MVDTESPICPLsP
2 0
PPAR-alpha (human) __MVDTEsPLCPLsP S6-p
PPAR-alpha (mouse) __MVDTESPICPLsP S6
PPAR-alpha (rat) __MVDTESPICPLSP S6
S12-p
ESPICPLsPLEADDL
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, induced
Regulatory protein:
  • CEPT1 (mouse)
Treatment
  • fenofibrate
PPAR-alpha (human) EsPLCPLsPLEAGDL S12-p
PPAR-alpha (mouse) ESPICPLsPLEADDL S12-p
PPAR-alpha (rat) ESPICPLSPLEADDL S12
S21-p
LEADDLEsPLSEEFL
Upstream
4 0
Treatment
  • adiponectin
PPAR-alpha (human) LEAGDLEsPLSEEFL S21-p
PPAR-alpha (mouse) LEADDLEsPLSEEFL S21-p
PPAR-alpha (rat) LEADDLESPLSEEFL S21
S45
SQSIGEESSGSFGFA
0 1
PPAR-alpha (human) SQSIGEDsSGSFGFT S45-p
PPAR-alpha (mouse) SQSIGEESSGSFGFA S45
PPAR-alpha (rat) SQSLGEESSGSFSFA S45
S73-p
SVITDTLsPASSPSS
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • GSK3B (human)
Regulatory protein:
  • BVR (mouse)
  • UGT1A1 (mouse)
PPAR-alpha (human) SVITDTLSPASSPSS S73
PPAR-alpha (mouse) SVITDTLsPASSPSS S73-p
PPAR-alpha (rat) SVITDTLSPASSPSS S73
S110
RICGDKASGYHYGVH
1 0
PPAR-alpha (human) RICGDKASGYHYGVH S110
PPAR-alpha (mouse) RICGDKASGYHYGVH S110
PPAR-alpha (rat) RICGDKAsGYHYGVH S110-p
T129
CKGFFRRTIRLKLVY
2 0
PPAR-alpha (human) CKGFFRRTIRLKLVY T129
PPAR-alpha (mouse) CKGFFRRTIRLKLVY T129
PPAR-alpha (rat) CKGFFRRtIRLKLAY T129-p
S142
VYDKCDRSCKIQKKN
1 0
PPAR-alpha (human) VYDKCDRSCKIQKKN S142
PPAR-alpha (mouse) VYDKCDRSCKIQKKN S142
PPAR-alpha (rat) AYDKCDRsCKIQKKN S142-p
S163
CRFHKCLSVGMSHNA
1 0
PPAR-alpha (human) CRFHKCLSVGMSHNA S163
PPAR-alpha (mouse) CRFHKCLSVGMSHNA S163
PPAR-alpha (rat) CRFHKCLsVGMSHNA S163-p
S179
RFGRMPRSEKAKLKA
2 0
PPAR-alpha (human) RFGRMPRsEKAKLkA S179-p
PPAR-alpha (mouse) RFGRMPRSEKAKLKA S179
PPAR-alpha (rat) RFGRMPRsEKAKLKA S179-p
K185
RSEKAKLKAEILTCE
1 0
PPAR-alpha (human) RsEKAKLkAEILTCE K185-sm
PPAR-alpha (mouse) RSEKAKLKAEILTCE K185
PPAR-alpha (rat) RsEKAKLKAEILTCE K185
K196-ub
LTCEHDLkDSETADL
0 1
PPAR-alpha (human) LTCEHDIEDSETADL E196
PPAR-alpha (mouse) LTCEHDLkDSETADL K196-ub
PPAR-alpha (rat) LTCEHDLKDSETADL K196
K204-ub
DSETADLkSLGKRIH
0 1
PPAR-alpha (human) DSETADLKSLAKRIY K204
PPAR-alpha (mouse) DSETADLkSLGKRIH K204-ub
PPAR-alpha (rat) DSETADLKSLAKRIH K204
A230
VKARVILAGKTSNNP
1 0
PPAR-alpha (human) VKARVILsGKASNNP S230-p
PPAR-alpha (mouse) VKARVILAGKTSNNP A230
PPAR-alpha (rat) VKARVILAGKTSNNP A230
S280-p
FHCCQCMsVETVTEL
Upstream
1 1
Putative in vivo kinases:
  • GSK3A (mouse)
Treatment
  • fenofibrate
  • high-fat diet
PPAR-alpha (human) FHCCQCTsVETVTEL S280-p
PPAR-alpha (mouse) FHCCQCMsVETVTEL S280-p
PPAR-alpha (rat) FHCCQCMSVETVTEL S280
K425-ub
DDTFLFPkLLQkMVD
0 1
PPAR-alpha (human) DDIFLFPKLLQKMAD K425
PPAR-alpha (mouse) DDTFLFPkLLQkMVD K425-ub
PPAR-alpha (rat) DDTFLFPKLLQKMVD K425
K429-ub
LFPkLLQkMVDLRQL
0 1
PPAR-alpha (human) LFPKLLQKMADLRQL K429
PPAR-alpha (mouse) LFPkLLQkMVDLRQL K429-ub
PPAR-alpha (rat) LFPKLLQKMVDLRQL K429
K449-ub
QLVQVIKkTEsDAAL
0 1
PPAR-alpha (human) QLVQIIKKTESDAAL K449
PPAR-alpha (mouse) QLVQVIKkTEsDAAL K449-ub
PPAR-alpha (rat) QLVQVIKKTESDAAL K449
S452-p
QVIKkTEsDAALHPL
1 0
PPAR-alpha (human) QIIKKTESDAALHPL S452
PPAR-alpha (mouse) QVIKkTEsDAALHPL S452-p
PPAR-alpha (rat) QVIKKTESDAALHPL S452